Andreassen, Ole A

Institute of Clinical Medicine, NORMENT Centre, University of Oslo, Oslo, Norway.

Title	Year	PMID
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.	2014	24399358
A comprehensive family-based replication study of schizophrenia genes.	2013	23894747
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.	2013	23933821
Common variants conferring risk of schizophrenia.	2009	19571808
The impact of divergence time on the nature of population structure: an example from Iceland.	2009	19503599
Large recurrent microdeletions associated with schizophrenia.	2008	18668039

Resolved affiliation

Institute of Clinical Medicine, NORMENT Centre, University of Oslo, Oslo, Norway.

Raw imported affiliations (22)

Affiliation
1] NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo N-0316, Norway. [2] NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0424, Norway.
Division of Mental Health and Addiction, Center for Precision Psychiatry, Oslo University Hospital, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. ole.andreassen@medisin.uio.no.
From the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, Washington University School of Medicine, St Louis; the Norwegian Centre for Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's College London, London; the National Institute for Health Research Biomedical Research Centre, South London and Maudsley National Health Service Trust, London; the Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the Institute of Neuroscience and Medicine, Juelich, Germany; the Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics Institute, University of Florida, Gainesville; the Department of Psychiatry, University of California-San Diego, La Jolla, Calif., the Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, U.K.
Institute of Clinical Medicine, NORMENT Centre, University of Oslo, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
NORMENT Center, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital, Oslo (Hindley, Frei, Shadrin, Cheng, O'Connell, Icick, Parker, Bahrami, Karadag, Roelfs, Holen, Lin, Smeland, Andreassen); Psychosis Studies, Institute of Psychiatry, Psychology, and Neurosciences, King's College London (Hindley); Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo (Frei); INSERM UMR-S1144, Université Paris Cité, Paris (Icick); Department of Cognitive Science (Fan), Multimodal Imaging Laboratory (Fan, Dale), and Departments of Psychiatry, Neurosciences, and Radiology (Dale), University of California, San Diego, La Jolla; Department of Medical Genetics, Oslo University Hospital, Oslo (Djurovic); NORMENT Center, Department of Clinical Science, University of Bergen, Bergen, Norway (Djurovic); KG Jebsen Center for Neurodevelopmental disorders, University of Oslo, Oslo (Shadrin, Djurovic, Andreassen).
NORMENT Centre, Division of Mental Health and Addiction, NORMENT Centre, University of Oslo, Oslo University Hospital, Oslo, Norway.
NORMENT Centre, Division of Mental Health and Addiction, University of Oslo, Oslo, Norway.
NORMENT, Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo, Norway. Electronic address: ole.andreassen@medisin.uio.no.
NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
NORMENT KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
NORMENT, K.G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
NORMENT, University of Oslo, Oslo, Norway.
NORMENT, University of Oslo, Oslo, Norway. ole.andreassen@medisin.uio.no.
Norwegian Centre for Mental Disorders Research (NORMENT), Oslo University Hospital, Oslo, Norway.
Oslo University Hospital, Division of Mental Health and Addiction, Oslo, Norway.